Skip to main content
AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)
Loading prices
Back to the NewsWire

UCSF

Published November 19, 2026 · Updated November 20, 2026

UCSF Launches Large-Scale Study of Psychedelics in the Real World | UC San Francisco

Read the full story at UCSF

UCSF researchers are launching CANOPY, an ambitious effort to study psychedelics in the real world, tracking thousands of people before and after.

Surfaced by 3 Google Alerts

  • Psychedelics
  • Psychedelics south america
  • Psychedelics africa